SE0023313762
SE0023313762
Apotea AB
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 7.203.300.000 | 6.541.100.000 | 10.1% |
| Cost of Revenue | 5.265.700.000 | 4.753.000.000 | 10.8% |
| Gross Profit | 1.937.600.000 | 1.788.100.000 | 8.4% |
| 1.633.900.000 | 1.525.300.000 | 7.1% | |
| Operating Income | 303.700.000 | 262.800.000 | 15.6% |
| Pretax Income | 289.800.000 | 264.700.000 | 9.5% |
| Net Income Common Stockholders | 228.700.000 | 214.900.000 | 6.4% |
| -- | -- | -- | |
| -- | -- | -- |